Showing posts with label MMWR. Show all posts
Showing posts with label MMWR. Show all posts

Sunday, January 28, 2018

UTI in pregnancy: nitrofurantoin and trimethoprim-sulfamethoxazole overprescribed despite potential risks.


Nitrofurantoin and trimethoprim-sulfamethoxazole were commonly prescribed for pregnant women during first trimester in 2014, despite the potential risk associated with these antibiotics, reports the results of analysis of large insurance database by Center for Disease Control(CDC). These findings were reported in the Morbidity and Mortality Weekly Report(MMWR) by CDC issued January 12, 2018.

Pregnant women are routinely screened for UTI in pregnancy and receive antibiotics if they screen positive, because of foreseen serious complication later in pregnancy like pyelonephritis, preterm labor, low birth weight, and sepsis.

ACOG recommends to being selective in prescribing antibiotics during first trimester because of potential of birth defects with certain antibiotics. ACOG recommends that nitrofurantoin and trimethoprim-sulfamethoxazole should only be prescribed in early pregnancy when other antibiotics are found ineffective.

CDC gathered data of about 482,917 pregnancies from Truven Health MarketScan Commercial Database and analyzed it for prescription filled for antibiotics during the first trimester.

All pregnant women between aged 15–44 years with a diagnosis of a UTI from 90 days before LMP through the end of pregnancy were identified to be included in the study. UTI was defined according to the International Classification of Diseases Ninth Revision, Clinical Modification (ICD-9 CM) diagnosis code or presence of cystitis with an outpatient prescription filled.

Women with recurrent UTI or those who were admitted were excluded from study.

The data showed that 34,864 (7.2%) pregnant women had an initial outpatient UTI claim 90 days before or during pregnancy.  UTI was most common during the first trimester (40%) and least common in the third trimester of pregnancy.

Types of antibiotics prescribed differed according to pregnancy status of women, with fluoroquinolones and sulfonamides more commonly prescribed to women within 90 days before their LMP while nitrofurantoin, cephalosporins and penicillins were the drugs of choice during pregnancy.

The most common antibiotics prescribed during the first trimester were nitrofurantoin (34.7%), ciprofloxacin (10.5%), cephalexin (10.3%), and trimethoprim-sulfamethoxazole (7.6%).

This report has its own limitations because UTI was identified only based on codes and not lab reports, some women may have other concomitant infections for which these antibiotics were prescribed, the MarketScan sample was a convenient sample hence could not be generalized to whole of US populations and out of pocket payee women were not included in the study.

Inspite of these limitations,  the report shows that it is important for all healthcare providers to be aware of antibiotic recommendations in pregnancy and be aware that they are prescribing for two in women who are pregnant or who might get pregnant in coming months.   





Tuesday, July 4, 2017

Eating your own placenta: CDC issues warning against this latest craze!


Courtesy: YouTube. 
Center for Disease Control(CDC) issued a warning in the weekly Morbidity and Mortality Weekly Report (MMWR) against consumption of placenta pills, after an Oregon infant recurrent illness was tied to maternal consumption of placenta pills.


Consumption of placenta in the form of pills or smoothies is called as Placentophagy and has become a recent trend, after it was touted by many celebrities to help mothers overcome postpartum depression, increase milk production and speeds up uterus involution, boosts energy, promotes skin elasticity, enhances maternal bonding and replenishes iron in the body.


In the Oregon case, after an uneventful labor and delivery in September 2016, the infant developed signs of respiratory distress and was admitted to NICU. Samples for Blood and cerebrospinal fluid (CSF) were obtained; presuming sepsis. CSF was negative but the blood tested positive for penicillin-sensitive, clindamycin-intermediate group B Streptococcus agalactiae (GBS). The infant made a full recovery after 11 days of treatment with ampicillin (200 mg/kg/day).

The infant was readmitted after 5 days to a second hospital and tested positive for late-onset group B Streptococcus agalactiae (GBS) bacteremia.

Digging deeper to unravel the mystery of infant’s recurrent infection, the doctors discovered that from the third postpartum day, the infant’s mother was consuming two capsules of her dehydrated placenta three times a day.

A physician at the birth hospital notified the authorities at the second hospital that the mother has requested a release of the placenta after delivery. The mother has already enlisted with a company that has agreed to turn the placenta into gelatin capsules after processing it. The company cleans, slices and dehydrates placentas at 115°F–160°F (46°C–71°C). The dried and powdered placenta is then filled into about 115 to 200 gel capsules.

The placenta capsules

One such company is placentapower which provides the entire package of collecting your placenta from place of labor to delivering the processed capsules to your doorstep for $250. Other services provided by the company includes placenta tincture, salve and prints. 

The three GBS isolates (one from each blood infection, and one from the placenta capsules) were indistinguishable by pulsed-field gel electrophoresis. Consumption of contaminated placenta capsules might have elevated maternal GBS intestinal and skin colonization, facilitating transfer to the infant.

No scientific evidence supports the benefits of consuming the afterbirth. Dr. Crystal Clark, assistant professor of psychiatry and behavioral sciences at Northwestern University Feinberg School of Medicine and a psychiatrist specializing in reproduction-related mood disorders at Northwestern’s Asher Center for the Study and Treatment of Depressive Disorders conducted a review of 10 current published research studies and found that no scientific evidence supports the benefits of consuming the afterbirth.

The study was published June 4 in Archives of Women's Mental Health.

A 2016 study from the University of Nevada Las Vegas, published in Journal of Midwifery and Women’s Health concluded, “ Encapsulated placenta supplementation neither significantly improves nor impairs postpartum maternal iron status for women consuming the RDA of dietary iron during pregnancy and lactation.”

The CDC MMWR reports warning says, “The placenta encapsulation process does not per se eradicate infectious pathogens; thus, placenta capsule ingestion should be avoided. In cases of maternal GBS colonization, chorioamnionitis, or early-onset neonatal GBS infection, ingestion of capsules containing contaminated placenta could heighten maternal colonization, thereby increasing an infant’s risk for late-onset neonatal GBS infection. Clinicians should inquire about a history of placenta ingestion in cases of late-onset GBS infection and educate mothers interested in placenta encapsulation about the potential risks.”

Ground placenta is used in traditional Chinese medicine since years. In North America, the first documented evidence of Placentophagy is around 1970s. Midwives and birthing doulas also prepare the capsules of placenta.

The full text of MMWR can be accessed here